Comparison between Curis Lifesciences IPO and Tenty IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Tenty IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | Tenty IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Finaax Capital Advisors Private Limited | Gretex Corporate Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | CB Management Services Pvt.Ltd. |
| Market Maker | RS Wealth Management Private Limited | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹26.14 Cr whereas the issue size of the Tenty IPO is up to ₹0.00 Cr. The final issue price of Curis Lifesciences IPO is ₹128.00 per share and of Tenty IPO is .
| Curis Lifesciences IPO | Tenty IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹120.00 per share | |
| Issue Price (Upper) | ₹128.00 per share | |
| Issue Price (Final) | ₹128.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 20,42,000 shares | 46,19,200 shares |
| Fresh Issue Size (Amount) | up to ₹26.14 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 20,42,000 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹26.14 Cr | up to ₹0.00 Cr |
Curis Lifesciences IPO opens on Nov 07, 2025, while Tenty IPO opens on . The closing date of Curis Lifesciences IPO and Tenty IPO is Nov 11, 2025, and , respectively.
| Curis Lifesciences IPO | Tenty IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2025 | |
| Issue Open | Nov 07, 2025 | |
| Issue Close | Nov 11, 2025 | |
| Basis Of Allotment (Tentative) | Nov 12, 2025 | |
| Initiation of Refunds (Tentative) | Nov 13, 2025 | |
| Credit of Share (Tentative) | Nov 13, 2025 | |
| Listing date (Tentative) | Nov 14, 2025 | |
| Anchor Lockin End date 1 | Dec 11, 2025 | |
| Anchor Lockin End date 2 | Feb 09, 2026 |
Curis Lifesciences IPO P/E ratio is 12.44, as compared to Tenty IPO P/E ratio of .
| Curis Lifesciences IPO | Tenty IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Curis Lifesciences Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 88.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹103.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.25 | 14.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.83 | 24.82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.96 | 0.36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 37.62 | 14.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 7,16,000 shares while in Tenty IPO retail investors are offered 7,16,000 shares. Qualified Institutional Buyers (QIB) are offered 4,08,000 shares in Curis Lifesciences IPO and in Tenty IPO.
| Curis Lifesciences IPO | Tenty IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,09,000 shares | |
| Market Maker Reservation | 1,08,000 shares | |
| QIB | 4,08,000 shares | |
| NII | 3,09,000 shares | |
| RII | 7,16,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 20,42,000 shares |
Curis Lifesciences IPO subscribed 74.39x in total, whereas Tenty IPO subscribed .
| Curis Lifesciences IPO | Tenty IPO | |
|---|---|---|
| QIB (times) | 96.17x | |
| NII (times) | 115.46x | |
| Big NII (times) | 142.74x | |
| Small NII (times) | 60.38x | |
| RII (times) | 44.28x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 74.39x |
